Federal Register of Legislation - Australian Government

Primary content

SLI 2010 No. 295 Regulations as made
These Regulations amend the National Health (Pharmaceutical Benefits) Regulations 1960 regarding provisions relevant to one drug, lercanidipine, on the Schedule which lists brands of pharmaceutical items scheduled for staged statutory price reductions.
Administered by: Health
Registered 25 Nov 2010
Tabling HistoryDate
Tabled HR08-Feb-2011
Tabled Senate08-Feb-2011
Date of repeal 19 Mar 2014
Repealed by Health (Spent and Redundant Instruments) Repeal Regulation 2014

National Health (Pharmaceutical Benefits) Amendment Regulations 2010 (No. 4)1

Select Legislative Instrument 2010 No. 295

I, QUENTIN BRYCE, Governor-General of the Commonwealth of Australia, acting with the advice of the Federal Executive Council, make the following Regulations under the National Health Act 1953.

Dated 24 November 2010

QUENTIN BRYCE

Governor-General

By Her Excellency’s Command

NICOLA ROXON


1              Name of Regulations

                These Regulations are the National Health (Pharmaceutical Benefits) Amendment Regulations 2010 (No. 4).

2              Commencement

                These Regulations commence on the day after they are registered.

3              Amendment of National Health (Pharmaceutical Benefits) Regulations 1960

                Schedule 1 amends the National Health (Pharmaceutical Benefits) Regulations 1960.


Schedule 1        Amendment

(regulation 3)

 

[1]           Schedule 5, table, item 5

substitute

5

Zanidip

Lercanidipine

Tablet 10 mg

Oral

1)  1 August 2008

2)  1 December 2010

1)   4%

2)   21%

Zanidip

Lercanidipine

Tablet 20 mg

Oral


Note

1.       All legislative instruments and compilations are registered on the Federal Register of Legislative Instruments kept under the Legislative Instruments Act 2003. See http://www.frli.gov.au.